CDKN2 Mutations in Melanoma
Overview
Authors
Affiliations
Schwochow Thalmann D, Ring H, Sundstrom E, Cao X, Larsson M, Kerje S PLoS Genet. 2017; 13(4):e1006665.
PMID: 28388616 PMC: 5384658. DOI: 10.1371/journal.pgen.1006665.
Cheadle E, Jackson A Immunology. 2002; 107(1):10-9.
PMID: 12225358 PMC: 1782780. DOI: 10.1046/j.1365-2567.2002.01498.x.
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
Ciotti P, Struewing J, Mantelli M, Chompret A, Avril M, Santi P Am J Hum Genet. 2000; 67(2):311-9.
PMID: 10869234 PMC: 1287180. DOI: 10.1086/303001.
Soufir N, Bressac-de Paillerets B, Desjardins L, Levy C, Bombled J, Gorin I Br J Cancer. 2000; 82(4):818-22.
PMID: 10732752 PMC: 2374387. DOI: 10.1054/bjoc.1999.1005.
Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop J, Harland M, Bennett D, Bataille V, Goldstein A, Tucker M Br J Cancer. 1999; 80(1-2):295-300.
PMID: 10390011 PMC: 2363010. DOI: 10.1038/sj.bjc.6690354.